Cargando…

Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events

AIMS: Although the bacterial virulent factor of cytotoxin-associated gene-A (CagA)-seropositivity and the host genetic factors of interleukin (IL)-1 polymorphisms have been suggested to influence Helicobacter pylori (HP) -related diseases, the underlying mechanisms of the association between HP infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Noriaki, Sueta, Daisuke, Arima, Yuichiro, Okamoto, Ken, Shono, Takashi, Hanatani, Shinsuke, Takashio, Seiji, Oniki, Kentaro, Saruwatari, Junji, Sakamoto, Kenji, Kaikita, Koichi, Sinning, Jan-Malte, Werner, Nikos, Nickenig, Georg, Sasaki, Yutaka, Fukui, Toshihiro, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062927/
https://www.ncbi.nlm.nih.gov/pubmed/32181324
http://dx.doi.org/10.1016/j.ijcha.2020.100498
_version_ 1783504611105046528
author Tabata, Noriaki
Sueta, Daisuke
Arima, Yuichiro
Okamoto, Ken
Shono, Takashi
Hanatani, Shinsuke
Takashio, Seiji
Oniki, Kentaro
Saruwatari, Junji
Sakamoto, Kenji
Kaikita, Koichi
Sinning, Jan-Malte
Werner, Nikos
Nickenig, Georg
Sasaki, Yutaka
Fukui, Toshihiro
Tsujita, Kenichi
author_facet Tabata, Noriaki
Sueta, Daisuke
Arima, Yuichiro
Okamoto, Ken
Shono, Takashi
Hanatani, Shinsuke
Takashio, Seiji
Oniki, Kentaro
Saruwatari, Junji
Sakamoto, Kenji
Kaikita, Koichi
Sinning, Jan-Malte
Werner, Nikos
Nickenig, Georg
Sasaki, Yutaka
Fukui, Toshihiro
Tsujita, Kenichi
author_sort Tabata, Noriaki
collection PubMed
description AIMS: Although the bacterial virulent factor of cytotoxin-associated gene-A (CagA)-seropositivity and the host genetic factors of interleukin (IL)-1 polymorphisms have been suggested to influence Helicobacter pylori (HP) -related diseases, the underlying mechanisms of the association between HP infection and acute coronary syndrome (ACS) remain unknown. METHODS AND RESULTS: Among 341 consecutive ACS patients, the clinical outcomes after ACS included composite cardiovascular events within the 2-year follow-up period. A significantly higher probability of primary outcomes was observed in HP positive patients than in HP negative patients. There were no significant differences in the rate of cardiovascular events between HP positive and HP negative patients in the absence of an IL-polymorphism, while there were significant differences in the presence of an IL-polymorphism. There were significant differences in the rate of cardiovascular events among CagA positive, CagA negative/ HP positive and CagA negative/HP negative patients. Moreover, via immunohistochemical staining, aortic CagA positive cells were confirmed in the vasa vasorum in CagA positive patients, whereas they could not be identified in CagA negative patients. CONCLUSIONS: The bacterial virulence factor CagA and host genetic IL-1 polymorphisms influence the incidence of adverse cardiovascular events, possibly through infection of atherosclerotic lesions. Registration: University Hospital Medical Information Network (UMIN)-CTR (http://www.umin.ac.jp/ctr/). Identifier: UMIN000035696.
format Online
Article
Text
id pubmed-7062927
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70629272020-03-16 Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events Tabata, Noriaki Sueta, Daisuke Arima, Yuichiro Okamoto, Ken Shono, Takashi Hanatani, Shinsuke Takashio, Seiji Oniki, Kentaro Saruwatari, Junji Sakamoto, Kenji Kaikita, Koichi Sinning, Jan-Malte Werner, Nikos Nickenig, Georg Sasaki, Yutaka Fukui, Toshihiro Tsujita, Kenichi Int J Cardiol Heart Vasc Original Paper AIMS: Although the bacterial virulent factor of cytotoxin-associated gene-A (CagA)-seropositivity and the host genetic factors of interleukin (IL)-1 polymorphisms have been suggested to influence Helicobacter pylori (HP) -related diseases, the underlying mechanisms of the association between HP infection and acute coronary syndrome (ACS) remain unknown. METHODS AND RESULTS: Among 341 consecutive ACS patients, the clinical outcomes after ACS included composite cardiovascular events within the 2-year follow-up period. A significantly higher probability of primary outcomes was observed in HP positive patients than in HP negative patients. There were no significant differences in the rate of cardiovascular events between HP positive and HP negative patients in the absence of an IL-polymorphism, while there were significant differences in the presence of an IL-polymorphism. There were significant differences in the rate of cardiovascular events among CagA positive, CagA negative/ HP positive and CagA negative/HP negative patients. Moreover, via immunohistochemical staining, aortic CagA positive cells were confirmed in the vasa vasorum in CagA positive patients, whereas they could not be identified in CagA negative patients. CONCLUSIONS: The bacterial virulence factor CagA and host genetic IL-1 polymorphisms influence the incidence of adverse cardiovascular events, possibly through infection of atherosclerotic lesions. Registration: University Hospital Medical Information Network (UMIN)-CTR (http://www.umin.ac.jp/ctr/). Identifier: UMIN000035696. Elsevier 2020-03-07 /pmc/articles/PMC7062927/ /pubmed/32181324 http://dx.doi.org/10.1016/j.ijcha.2020.100498 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
Tabata, Noriaki
Sueta, Daisuke
Arima, Yuichiro
Okamoto, Ken
Shono, Takashi
Hanatani, Shinsuke
Takashio, Seiji
Oniki, Kentaro
Saruwatari, Junji
Sakamoto, Kenji
Kaikita, Koichi
Sinning, Jan-Malte
Werner, Nikos
Nickenig, Georg
Sasaki, Yutaka
Fukui, Toshihiro
Tsujita, Kenichi
Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
title Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
title_full Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
title_fullStr Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
title_full_unstemmed Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
title_short Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events
title_sort cytotoxin-associated gene-a-seropositivity and interleukin-1 polymorphisms influence adverse cardiovascular events
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062927/
https://www.ncbi.nlm.nih.gov/pubmed/32181324
http://dx.doi.org/10.1016/j.ijcha.2020.100498
work_keys_str_mv AT tabatanoriaki cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT suetadaisuke cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT arimayuichiro cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT okamotoken cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT shonotakashi cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT hanatanishinsuke cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT takashioseiji cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT onikikentaro cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT saruwatarijunji cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT sakamotokenji cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT kaikitakoichi cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT sinningjanmalte cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT wernernikos cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT nickeniggeorg cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT sasakiyutaka cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT fukuitoshihiro cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents
AT tsujitakenichi cytotoxinassociatedgeneaseropositivityandinterleukin1polymorphismsinfluenceadversecardiovascularevents